Psilocybin’s therapeutic benefits have been recognized by the medical industry too. The Johns Hopkins Center for Psychedelic and Consciousness Research has invested in a psychedelic and psilocybin therapy and research center, thanks to $17 million in funding, so that researchers can learn more about psychedelics, how they can help treat illness, and develop new treatments for behavioral disorders.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…